Tag: AI in pharma
-
Recent Advances in Bioequivalence Testing: Emerging Technologies Shaping Generic Drug Approval
Recent advances in bioequivalence testing, including AI-driven analysis, virtual models, and advanced imaging, are transforming how generic and biosimilar drugs are approved. These technologies reduce costs, speed up reviews, and improve accuracy-especially for complex formulations.